跳至主要内容
临床试验/NCT02209129
NCT02209129Unknown不适用

3D Digital Breast Tumorsynthesis Versus 2D Digital Mammography in the Clinical Evaluation of Women at High Risk for Breast Cancer

Universitaire Ziekenhuizen KU Leuven1 个研究点 分布在 1 个国家目标入组 1,000 人开始时间: 2014年8月最近更新:
适应症

试验速览

阶段
不适用
入组人数
1,000
试验地点
1
主要终点
Tumor dectection rate

研究概览

简要总结

Patients with a higher breast cancer risk (higher than 17% according to the IBIS calculation) will receive a 2D digital mammography together with a 3D tomosynthesis (so called combo tomo) of both breasts in two views in order to investigate the additional value of tomosynthesis in the diagnosis of breast cancer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
40 Years 至 90 Years(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • more than 17% risk for breast cancer (IBIS calculation)
  • > 40y old

排除标准

  • < 40y old

结局指标

主要结局

Tumor dectection rate

时间窗: 2 years

The addititional value of 3D tomosythesis to 2D digital mammography will be evaluated by the cancer detection rate, falls negative and falls positive results.

次要结局

  • Falls negative, Falls positive results, accuracy(4 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chantal Van Ongeval, MD, Phd

Prof. dr. Van Ongeval Chantal

Universitaire Ziekenhuizen KU Leuven

研究点 (1)

Loading locations...

相似试验